Skip to main content
Signal8
MOATAZEDI DAVID profile photo

David Moatazedi

CIK: 0001700836

Transaction Breakdown

Open Market Buys (P)1 (6.3%)

High conviction signal

Open Market Sales (S)10 (62.5%)

Position reduction

Option Exercises (M)1 (6.3%)

Derivative conversions

Awards (A)4 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Evolus, Inc. logo
EOLS

Evolus, Inc.

DirectorOfficer
BIOMERICA INC logo
BMRA

BIOMERICA INC

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Sep 2, 2026
    Sale(S)
    Direct
    105.1K shares at avg. $9.04$950K
  • BIOMERICA INC logo
    BMRA

    BIOMERICA INC

    Aug 26, 2026
    Purchase(P)
    Direct
    10K shares at avg. $1.60$16K
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Mar 20, 2026
    Sale(S)
    Direct
    13.7K shares at avg. $4.75$65K
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Mar 17, 2026
    Sale(S)
    Direct
    116.7K shares at avg. $4.89$571K
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Mar 16, 2026
    Exercise(M)
    Direct
    67.5K shares-
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Feb 17, 2026
    Award(A)
    Direct
    313.2K shares-
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Dec 22, 2025
    Sale(S)
    Direct
    10.5K shares at avg. $7.15$75K
  • BIOMERICA INC logo
    BMRA

    BIOMERICA INC

    Dec 12, 2025
    Award(A)
    Direct
    20K shares-
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Jun 16, 2025
    Sale(S)
    Direct
    16.6K shares at avg. $9.89$164K
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Jun 13, 2025
    Sale(S)
    Direct
    111.3K shares at avg. $10.05$1.1M
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    May 12, 2025
    Sale(S)
    Direct
    15.8K shares at avg. $9.87$156K
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Mar 27, 2025
    Sale(S)
    Direct
    6.3K shares at avg. $12.40$78K
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Mar 18, 2025
    Sale(S)
    Direct
    103.4K shares at avg. $13.26$1.4M
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Mar 7, 2025
    Award(A)
    Direct
    95.4K shares-
  • Evolus, Inc. logo
    EOLS

    Evolus, Inc.

    Dec 23, 2024
    Sale(S)
    Direct
    10.5K shares at avg. $10.85$114K
  • BIOMERICA INC logo
    BMRA

    BIOMERICA INC

    Dec 13, 2024
    Award(A)
    Direct
    85K shares at avg. $0.31$26K

1-16 of 16

About MOATAZEDI DAVID

MOATAZEDI DAVID (SEC CIK 0001700836) files insider reports with the SEC as Director of Evolus, Inc. (EOLS) and Director of BIOMERICA INC (BMRA).

Signal8 holds 14 ownership filings by MOATAZEDI DAVID, all Form 4s, filed between Dec 17, 2024 and Sep 4, 2026. Those filings report 16 transactions, from Dec 13, 2024 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MOATAZEDI DAVID's filings is in NEWPORT BEACH, CA.

Recent filings by MOATAZEDI DAVID

  • Sep 2, 2026: Open-market sale of EOLS shares (Form 4, code S).
  • Aug 26, 2026: Open-market purchase of BMRA shares (Form 4, code P).
  • Mar 20, 2026: Open-market sale of EOLS shares (Form 4, code S).
  • Mar 17, 2026: Open-market sale of EOLS shares (Form 4, code S).
  • Mar 16, 2026: Option exercise of EOLS shares (Form 4, code M).

Other insiders filing for Evolus, Inc. (EOLS)

How to read Form 4 transaction codes